Learning objectives

After watching this webinar, participants will be aware of:

• presentation and implementation of the new 2022 ESC/ERS Guidelines on PH;
• updated definitions, diagnosis and differential diagnosis of PH;
• treatment and risk stratification in pulmonary arterial hypertension (Group 1 PH); and
• specific aspects of PH associated with left-sided heart disease (Group 2 PH) and PH associated with lung disease (Group 3 PH).

Need assessment and expected educational outcome 

To understand:

• the rationale for the updated haemodynamic definitions of PH and the strategy for a comprehensive diagnostic workup;
• how updated ESC/ERS Guidelines for treating PAH have been simplified to provide a clear focus on risk assessment, cardiopulmonary comorbidities, and treatment goals; and
• the pathophysiology and management strategies for PH associated with left heart or lung diseases. 

Main topic

• Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure

Session information

This webinar is designed for general cardiologists and specialists working in the following fields: 

• Pulmonary Circulation-Pulmonary Embolism-Right Heart Failure; 
• Heart Failure; 
• Valvular Heart Disease; 
• Congenital Heart Disease and Pediatric Cardiology; 
• Cardiovascular Disease in the Elderly;
• Cardiovascular Pharmacology / Pharmacology and Pharmacotherapy; and
• Echocardiography and General Imaging.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Looking for more essentials on the New ESC Guidelines on Pulmonary Hypertension? Watch the ESC 2022 Clinical Practice Guidelines on Pulmonary Hypertension webinar on-demand here.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).